Option Care Health (NYSE: OPCH), the home-based and alternate site infusion services provider, had one heck of a 2023. But, about six months removed from its failed attempt to acquire Amedisys Inc. (Nasdaq: AMED), it still remains a home-based care provider worth paying attention to. On Tuesday at the J.P. Morgan Healthcare Conference, the company’s […]
Option Care Health
Option Care Health (Nasdaq: OPCH) came out on the losing end of a bidding process for Amedisys Inc. (Nasdaq: AMED) earlier this year. The winner of that process, of course, was UnitedHealth Group’s (NYSE: UNH) Optum. That transaction is still pending, but will likely be finalized in the first half of 2024. Before Optum came […]
On May 3, Amedisys Inc. (Nasdaq: AMED) and Option Care Health (Nasdaq: OPCH) issued a joint press release announcing their intent to merge. By June 5, those plans were complicated, with Amedisys revealing it had received a competing bid from UnitedHealth Group’s (NYSE: UNH) Optum. They were then scrapped entirely when, on the morning of […]
Although leaders at UnitedHealth Group (NYSE: UNH) were relatively quiet about the deal for its Optum arm to acquire Amedisys Inc. (Nasdaq: AMED) during a Friday Q2 earnings call, they did touch on the high-level strategic fit. In fact, UnitedHealth Group CEO Andrew Witty doubled down on his company’s focus and investment in the home […]
Paul Mastrapa is replacing Jennifer Sheets as CEO of Interim HealthCare, the company announced Friday. Sheets had served as the president and CEO of Interim since January of 2019. She also served as the president and CEO of Caring Brands International, the parent company of Interim, the U.K.-based Bluebird Care and the Australia-based Just Better […]
Option Care Health (Nasdaq: OPCH) announced its plans to acquire Amedisys Inc. (Nasdaq: AMED) at the beginning of May. In early June, competition arrived, as UnitedHealth Group’s (NYSE: UNH) Optum put in its own bid to acquire Amedisys. For Option Care Health, the deal was its way to create an end-to-end health care continuum in […]
UnitedHealth Group’s (NYSE: UNH) Optum has made an unsolicited proposal to acquire all of the outstanding shares of Amedisys’ common stock in an all-cash transaction for $100 per share, the latter announced Monday morning. This could represent a “superior proposal” to Option Care Health’s (Nasdaq: OPCH) proposed deal for Amedisys. Option Care Health and Amedisys […]
Amedisys Inc. (Nasdaq: AMED) is expected to merge with Option Care Health (Nasdaq: OPCH) in the back half of 2023. The deal, which valued the former at $3.6 billion, was announced at the beginning of May. The shareholders of each company still have to approve the deal. In the meantime, the two companies released a […]
Whether it’s because of their proven leadership teams looking to shake up the market or their roles in a jaw-dropping transaction, there are several home health providers that stand out among their peers in 2023. And the moves that these companies – new players and established powerhouses alike – make over the next 6-12 months […]
Amedisys Inc. (Nasdaq: AMED) is answering more questions about its potential merger with Option Care Health (Nasdaq: OPCH), which was first announced earlier this month. The company submitted these responses as part of a 425 SEC filing, which it added to its site for stakeholders, employees and the public to view on Thursday. A number […]
Subscribe
Receive industry updates and breaking news from HHCN